We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EW icon
151
Edwards Lifesciences
EW
$53.6B
$11.1M 0.13%
160,705
-581
-0.4% -$41.3K
EL icon
152
Estee Lauder
EL
$31.7B
$11.1M 0.13%
58,784
+1,419
+2% +$254K
WM icon
153
Waste Management
WM
$90.5B
$10.8M 0.12%
101,545
+940
+0.9% +$94.9K
ROP icon
154
Roper Technologies
ROP
$39.1B
$10.6M 0.12%
27,304
+481
+2% +$172K
AEP icon
155
American Electric Power
AEP
$67.9B
$10.2M 0.12%
128,525
+1,203
+0.9% +$98.2K
DD icon
156
DuPont de Nemours
DD
$19.5B
$10.2M 0.12%
152,891
+766
+0.5% +$44.7K
SCHW
157
Charles Schwab
SCHW
$189B
$10.1M 0.12%
299,668
+4,974
+2% +$178K
DLR icon
158
Digital Realty Trust
DLR
$72.9B
$9.97M 0.11%
70,174
+2,419
+4% +$342K
EA
159
DELISTED
Electronic Arts
EA
$9.97M 0.11%
75,502
+241
+0.3% +$28.5K
DXCM icon
160
DexCom
DXCM
$34.3B
$9.79M 0.11%
+96,564
New +$8.64M
GIS icon
161
General Mills
GIS
$20.4B
$9.77M 0.11%
158,527
+2,737
+2% +$165K
EMR icon
162
Emerson Electric
EMR
$91.4B
$9.69M 0.11%
156,261
-756
-0.5% -$42.9K
CNC icon
163
Centene
CNC
$33.1B
$9.63M 0.11%
151,463
+979
+0.7% +$63.7K
LHX icon
164
L3Harris
LHX
$54.1B
$9.58M 0.11%
56,458
-524
-0.9% -$98.5K
EXC icon
165
Exelon
EXC
$46.6B
$9.25M 0.11%
357,290
+5,987
+2% +$159K
ETN icon
166
Eaton
ETN
$179B
$9.15M 0.1%
104,614
-1,945
-2% -$160K
GD icon
167
General Dynamics
GD
$107B
$9.08M 0.1%
60,771
+367
+0.6% +$51.8K
EBAY icon
168
eBay
EBAY
$45.5B
$9.06M 0.1%
172,749
-24,365
-12% -$1.03M
SRE icon
169
Sempra
SRE
$56.2B
$8.97M 0.1%
153,016
+7,692
+5% +$473K
FDX icon
170
FedEx
FDX
$77.3B
$8.81M 0.1%
62,860
+988
+2% +$124K
TRGP icon
171
Targa Resources
TRGP
$57.6B
$8.79M 0.1%
437,959
+93,500
+27% +$1.41M
SBAC icon
172
SBA Communications
SBAC
$19.4B
$8.7M 0.1%
29,194
+169
+0.6% +$49.9K
XEL icon
173
Xcel Energy
XEL
$49.1B
$8.58M 0.1%
137,314
+2,147
+2% +$135K
GM icon
174
General Motors
GM
$76.1B
$8.33M 0.09%
329,366
+5,273
+2% +$128K
TER icon
175
Teradyne
TER
$63B
$8.32M 0.09%
98,442
+2,250
+2% +$151K

Similar funds

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.